GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Inventories, Raw Materials & Components

BCAX (Bicara Therapeutics) Inventories, Raw Materials & Components : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Inventories, Raw Materials & Components?

Bicara Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $0.00 Mil.


Bicara Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Bicara Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics Inventories, Raw Materials & Components Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
- - -

Bicara Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial - - - - -

Bicara Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Bicara Therapeutics Business Description

Industry
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.